3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with Arthritis, Rheumatoid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, K; Itoh, H; Maeshima, K; Oda, A; Ohno, K; Ono, H; Ozaki, T; Shibata, H; Suzuki, Y; Tanaka, R; Tatsuta, R | 1 |
1 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid Arthritis.
Topics: Aged; Arthritis, Rheumatoid; Biomarkers; Coproporphyrins; Female; Furans; Humans; Interleukin-6; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Pharmacogenomic Variants; Propionates; Tumor Necrosis Factor-alpha | 2021 |